{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T04:07:19Z","timestamp":1790482039794,"version":"4.1.0"},"reference-count":74,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,10,26]],"date-time":"2021-10-26T00:00:00Z","timestamp":1635206400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006507","name":"Funda\u00e7\u00e3o Oswaldo Cruz","doi-asserted-by":"publisher","award":["INOVA program - FIOCRUZ (grant number VPPCB-008-FIO-18-2-39)"],"award-info":[{"award-number":["INOVA program - FIOCRUZ (grant number VPPCB-008-FIO-18-2-39)"]}],"id":[{"id":"10.13039\/501100006507","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Human T-lymphotropic virus type 1 (HTLV-1)-associated myelopathy\/tropical spastic paraparesis (HAM\/TSP) is a neurodegenerative disease due to axonal damage of the corticospinal secondary to an inflammatory response against infected T-cells. In the present work, we aimed to evaluate biomarkers of neurodegeneration and neuroinflammation in the definition of HAM\/TSP prognosis. Neurofilament light (NfL) and phosphorylated heavy (pNfH) chains, total Tau protein, cellular prion protein (PrPc), inflammatory chemokines, and neopterin were quantified in paired cerebrospinal fluid (CSF) and serum samples from HAM\/TSP patients (n=21), HTLV-1 asymptomatic carriers (AC) (n=13), and HTLV-1 seronegative individuals with non-inflammatory non-degenerative neurological disease (normal-pressure hydrocephalus) (n=9) as a control group. HTLV-1 proviral load in peripheral blood mononuclear cells and the expression of chemokine receptors CCR4, CCR5, and CXCR3 in infected CD4<jats:sup>+<\/jats:sup> T-cells (HTLV-1 Tax<jats:sup>+<\/jats:sup> cells) were also assessed. CSF levels of Tau, NfL, and pNfH were similar between groups, but PrPc and neopterin were elevated in HAM\/TSP patients. Most individuals in the control group and all HTLV-1 AC had CSF\/serum neopterin ratio &amp;lt; 1.0, and two-thirds of HAM\/TSP patients had ratio values &amp;gt; 1.0, which positively correlated with the speed of disease progression and pNfH levels, indicating active neuroinflammation. HAM\/TSP patients showed high serum levels of CXCR3-binding chemokines (CXCL9, CXCL10, and CXCL11) and elevated CSF levels of CCL2, CCL3, CCL4, CCL17, CXCL5, CXCL10, and CXCL11. Indeed, CXCL10 concentration in CSF of HAM\/TSP patients was 5.8-fold and 8.7-fold higher in than in HTLV-1 AC and controls, respectively, and correlated with CSF cell counts. HAM\/TSP patients with typical\/rapid disease progression had CSF\/serum CXCL10 ratio &amp;gt; 1.0 and a higher frequency of CXCR3<jats:sup>+<\/jats:sup>Tax<jats:sup>+<\/jats:sup>CD4<jats:sup>+<\/jats:sup> T-cells in blood, which indicated a positive gradient for the migration of infected cells and infiltration into the central nervous system. In conclusion, the slow progression of HAM\/TSP abrogates the usefulness of biomarkers of neuronal injury for the disease prognosis. Thus, markers of inflammation provide stronger evidence for HAM\/TSP progression, particularly the CSF\/serum neopterin ratio, which may contribute to overcome differences between laboratory assays.<\/jats:p>","DOI":"10.3389\/fimmu.2021.737941","type":"journal-article","created":{"date-parts":[[2021,10,26]],"date-time":"2021-10-26T07:20:54Z","timestamp":1635232854000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":32,"title":["Following the Clues: Usefulness of Biomarkers of Neuroinflammation and Neurodegeneration in the Investigation of HTLV-1-Associated Myelopathy Progression"],"prefix":"10.3389","volume":"12","author":[{"given":"Fl\u00e1via dos Santos","family":"Souza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole Lardini","family":"Freitas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yago C\u00f4rtes Pinheiro","family":"Gomes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael\u00a0Carvalho","family":"Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliana","family":"Echevarria-Lima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isaac Lima da","family":"Silva-Filho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana\u00a0Claudia Celestino Bezerra","family":"Leite","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco Antonio Sales Dantas de","family":"Lima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus\u00a0Tulius Teixeira da","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abelardo de Queiroz Campos","family":"Ara\u00fajo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ot\u00e1vio Melo","family":"Esp\u00edndola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,10,26]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2012.00388","article-title":"Epidemiological Aspects and World Distribution of HTLV-1 Infection","volume":"3","author":"Gessain","year":"2012","journal-title":"Front Microbiol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(06)70628-7","article-title":"The HTLV-1 Neurological Complex","volume":"5","author":"Araujo","year":"2006","journal-title":"Lancet Neurol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"15012","DOI":"10.1038\/nrdp.2015.12","article-title":"HTLV-1-Associated Myelopathy\/Tropical Spastic Paraparesis","volume":"1","author":"Bangham","year":"2015","journal-title":"Nat Rev Dis Primers"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1038\/sc.2012.134","article-title":"Falls in Patients With HTLV-I-Associated Myelopathy\/Tropical Spastic Paraparesis (HAM\/TSP)","volume":"51","author":"Facchinetti","year":"2013","journal-title":"Spinal Cord"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1080\/13550280701510096","article-title":"Subacute Progression of Human T-Lymphotropic Virus Type I-Associated Myelopathy\/Tropical Spastic Paraparesis","volume":"13","author":"Lima","year":"2007","journal-title":"J Neurovirol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V50.3.481.481","article-title":"Adult T-Cell Leukemia: Clinical and Hematologic Features of 16 Cases","volume":"50","author":"Uchiyama","year":"1977","journal-title":"Blood"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.2741\/3300","article-title":"Role of Resident CNS Cell Populations in HTLV-1-Associated Neuroinflammatory Disease","volume":"14","author":"Lepoutre","year":"2009","journal-title":"Front Biosci (Landmark Ed)"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1089\/aid.2006.22.931","article-title":"Proposal for Diagnostic Criteria of Tropical Spastic Paraparesis\/HTLV-I-Associated Myelopathy (TSP\/HAM)","volume":"22","author":"De Castro-Costa","year":"2006","journal-title":"AIDS Res Hum Retroviruses"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1038\/sc.2015.112","article-title":"Neurological Manifestations in Individuals With HTLV-1-Associated Myelopathy\/Tropical Spastic Paraparesis in the Amazon","volume":"54","author":"Dias","year":"2016","journal-title":"Spinal Cord"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/0022-510X(90)90217-B","article-title":"Elevated Levels of Interleukin-6 in Serum and Cerebrospinal Fluid of HTLV-I-Associated Myelopathy\/Tropical Spastic Paraparesis","volume":"97","author":"Nishimoto","year":"1990","journal-title":"J Neurol Sci"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/0165-5728(93)90001-F","article-title":"Detection of Tumor Necrosis Factor-\u03b1-Positive Cells in Cerebrospinal Fluid of Patients With HTLV-I-Associated Myelopathy","volume":"42","author":"Nakamura","year":"1993","journal-title":"J Neuroimmunol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-5728(98)00263-X","article-title":"Elevated Levels of Interleukin-12 and Interferon-Gamma in Patients With Human T Lymphotropic Virus Type I-Associated Myelopathy","volume":"95","author":"Furuya","year":"1999","journal-title":"J Neuroimmunol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0900069","article-title":"The Avidity and Lytic Efficiency of the CTL Response to HTLV-1","volume":"182","author":"Kattan","year":"2009","journal-title":"J Immunol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiq078","article-title":"In Vivo Expression of Human T-Lymphotropic Virus Type 1 Basic Leucine-Zipper Protein Generates Specific CD8+ and CD4+ T-Lymphocyte Responses That Correlate With Clinical Outcome","volume":"203","author":"Hilburn","year":"2011","journal-title":"J Infect Dis"},{"key":"B15","doi-asserted-by":"publisher","first-page":"e1002480","DOI":"10.1371\/journal.ppat.1002480","article-title":"Systems Biology Approaches Reveal a Specific Interferon-Inducible Signature in HTLV-1 Associated Myelopathy","volume":"8","author":"Tattermusch","year":"2012","journal-title":"PloS Pathog"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1097\/00005072-199307000-00010","article-title":"Immunocytochemical Analysis of the Cellular Infiltrate in the Spinal Cord Lesions in HTLV-I-Associated Myelopathy","volume":"52","author":"Umehara","year":"1993","journal-title":"J Neuropathol Exp Neurol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awt183","article-title":"Positive Feedback Loop via Astrocytes Causes Chronic Inflammation in Virus-Associated Myelopathy","volume":"136","author":"Ando","year":"2013","journal-title":"Brain"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3109\/13550289809114225","article-title":"Analysis of HTLV-I Proviral Load in 202 HAM\/TSP Patients and 243 Asymptomatic HTLV-I Carriers: High Proviral Load Strongly Predisposes to HAM\/TSP","volume":"4","author":"Nagai","year":"1998","journal-title":"J Neurovirol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2005.05.010","article-title":"HTLV-1 Proviral Load in Peripheral Blood Mononuclear Cells Quantified in 100 HAM\/TSP Patients: A Marker of Disease Progression","volume":"237","author":"Olindo","year":"2005","journal-title":"J Neurol Sci"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1086\/510679","article-title":"Human T Lymphotropic Virus Type 1 (HTLV-1) Proviral Load in Asymptomatic Carriers, HTLV-1\u2013Associated Myelopathy\/Tropical Spastic Paraparesis, and Other Neurological Abnormalities Associated With HTLV-1 Infection","volume":"44","author":"Silva","year":"2007","journal-title":"Clin Infect Dis"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1086\/429962","article-title":"Human T Lymphotropic Virus Type I (HTLV-I) Proviral Load in Cerebrospinal Fluid: A New Criterion for the Diagnosis of HTLV-I\u2013Associated Myelopathy\/Tropical Spastic Paraparesis","volume":"191","author":"Lezin","year":"2005","journal-title":"J Infect Dis"},{"key":"B22","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1080\/13550280390173418","article-title":"Usefulness of Proviral Load Measurement for Monitoring of Disease Activity in Individual Patients With Human T-Lymphotropic Virus Type I-Associated Myelopathy\/Tropical Spastic Paraparesis","volume":"9","author":"Takenouchi","year":"2003","journal-title":"J Neurovirol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-006-0481-8","article-title":"CSF Neurofilament Protein (NFL) \u2014 A Marker of Active HIV-Related Neurodegeneration","volume":"254","author":"Abdulle","year":"2007","journal-title":"J Neurol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2377-9-63","article-title":"Amyloid and Tau Cerebrospinal Fluid Biomarkers in HIV Infection","volume":"9","author":"Gisslen","year":"2009","journal-title":"BMC Neurol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1177\/1352458512443092","article-title":"Neurofilaments as Biomarkers in Multiple Sclerosis","volume":"18","author":"Teunissen","year":"2012","journal-title":"Mult Scler"},{"key":"B26","doi-asserted-by":"publisher","first-page":"e116081","DOI":"10.1371\/journal.pone.0116081","article-title":"Cerebrospinal Fluid (CSF) Neuronal Biomarkers Across the Spectrum of HIV Infection: Hierarchy of Injury and Detection","volume":"9","author":"Peterson","year":"2014","journal-title":"PloS One"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1038\/s41582-018-0058-z","article-title":"Neurofilaments as Biomarkers in Neurological Disorders","volume":"14","author":"Khalil","year":"2018","journal-title":"Nat Rev Neurol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1177\/1352458509359725","article-title":"Neurofilament Light as a Prognostic Marker in Multiple Sclerosis","volume":"16","author":"Salzer","year":"2010","journal-title":"Multiple Sclerosis J"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-014-7507-4","article-title":"N-Acetylaspartate and Neurofilaments as Biomarkers of Axonal Damage in Patients With Progressive Forms of Multiple Sclerosis","volume":"261","author":"Trentini","year":"2014","journal-title":"J Neurol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"e88591","DOI":"10.1371\/journal.pone.0088591","article-title":"Biomarker Evidence of Axonal Injury in Neuroasymptomatic HIV-1 Patients","volume":"9","author":"Jessen Krut","year":"2014","journal-title":"PloS One"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.3390\/biom6020021","article-title":"New Features About Tau Function and Dysfunction","volume":"6","author":"Medina","year":"2016","journal-title":"Biomolecules"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0609621104","article-title":"Cellular Prion Protein Regulates Beta-Secretase Cleavage of the Alzheimer\u2019s Amyloid Precursor Protein","volume":"104","author":"Parkin","year":"2007","journal-title":"Proc Natl Acad Sci"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2007.02.011","article-title":"The Cellular Prion Protein (PrPC): Its Physiological Function and Role in Disease","volume":"1772","author":"Westergard","year":"2007","journal-title":"Biochim Biophys Acta"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1007\/s00702-007-0013-4","article-title":"Expression of Cellular Prion Protein (PrPc) in Schizophrenia, Bipolar Disorder, and Depression","volume":"115","author":"Weis","year":"2008","journal-title":"J Neural Transm"},{"key":"B35","doi-asserted-by":"publisher","first-page":"e36159","DOI":"10.1371\/journal.pone.0036159","article-title":"Altered Prion Protein Expression Pattern in CSF as a Biomarker for Creutzfeldt-Jakob Disease","volume":"7","author":"Torres","year":"2012","journal-title":"PloS One"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M103289200","article-title":"PrPC Directly Interacts With Proteins Involved in Signaling Pathways","volume":"276","author":"Spielhaupter","year":"2001","journal-title":"J Biol Chem"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1365-2249.2006.03194.x","article-title":"The Role of the Cellular Prion Protein in the Immune System","volume":"146","author":"Isaacs","year":"2006","journal-title":"Clin Exp Immunol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.2353\/ajpath.2010.091006","article-title":"PrPC, the Cellular Isoform of the Human Prion Protein, Is a Novel Biomarker of HIV-Associated Neurocognitive Impairment and Mediates Neuroinflammation","volume":"177","author":"Roberts","year":"2010","journal-title":"Am J Pathol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"e2479","DOI":"10.1371\/journal.pntd.0002479","article-title":"CSF CXCL10, CXCL9, and Neopterin as Candidate Prognostic Biomarkers for","volume":"7","author":"Sato","year":"2013","journal-title":"PloS Negl Trop Dis"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2018.01651","article-title":"Proposal of Classification Criteria for HTLV-1-Associated Myelopathy\/Tropical Spastic Paraparesis Disease Activity","volume":"9","author":"Sato","year":"2018","journal-title":"Front Microbiol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2019.02110","article-title":"Cerebrospinal Fluid CXCL10 as a Candidate Surrogate Marker for HTLV-1-Associated Myelopathy\/Tropical Spastic Paraparesis","volume":"10","author":"Tamaki","year":"2019","journal-title":"Front Microbiol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"P03.258","DOI":"10.1212\/WNL.78.1_MeetingAbstracts.P03.258","article-title":"Development and Validation of a Neurological Disability Scale for Patients With HTLV-1 Associated Myelopathy\/Tropical Spastic Paraparesis (HAM\/TSP): The IPEC-1 Scale (P03.258)","volume":"78","author":"Schmidt","year":"2012","journal-title":"Neurology"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"\u201cMini-Mental State\u201d. A Practical Method for Grading the Cognitive State of Patients for the Clinician","volume":"12","author":"Folstein","year":"1975","journal-title":"J Psychiatr Res"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.2004.035709","article-title":"Gender Influence on the Progression of HTLV-I Associated Myelopathy\/Tropical Spastic Paraparesis","volume":"76","author":"Lima M a","year":"2005","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1002\/JLB.MA1118-467R","article-title":"Phenotypic and Functional Changes in Gamma Delta T Lymphocytes From HTLV-1 Carriers","volume":"106","author":"Cavalcanti De Albuquerque","year":"2019","journal-title":"J Leukocyte Biol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1093\/clinchem\/47.10.1776","article-title":"Tau and Abeta42 in Cerebrospinal Fluid From Healthy Adults 21-93 Years of Age: Establishment of Reference Values","volume":"47","author":"Sj\u00f6gren","year":"2001","journal-title":"Clin Chem"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/168.5.1285","article-title":"Cerebrospinal Fluid Neopterin Concentrations in Central Nervous System Infection","volume":"168","author":"Hagberg","year":"1993","journal-title":"J Infect Dis"},{"key":"B48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2013\/196432","article-title":"Neopterin in Diagnosis and Monitoring of Infectious Diseases","volume":"2013","author":"Eisenhut","year":"2013","journal-title":"J Biomarkers"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2016.08.012","article-title":"HTLV-1 Induces a Th1-Like State in CD4+CCR4+ T Cells That Produces an Inflammatory Positive Feedback Loop via Astrocytes in HAM\/TSP","volume":"304","author":"Yamano","year":"2017","journal-title":"J Neuroimmunol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1172\/JCI75250","article-title":"HTLV-1 Induces a Th1-Like State in CD4+CCR4+ T Cells","volume":"124","author":"Araya","year":"2014","journal-title":"J Clin Invest"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1089\/aid.2007.0077","article-title":"Brain Magnetic Resonance Imaging White Matter Lesions Are Frequent in HTLV-I Carriers and Do Not Discriminate From HAM\/TSP","volume":"23","author":"Morgan","year":"2007","journal-title":"AIDS Res Hum Retroviruses"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1086\/344266","article-title":"The Chemokine System in Neuroinflammation: An Update","volume":"186","author":"Ransohoff","year":"2002","journal-title":"J Infect Dis"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1590\/S1679-45082015RB3438","article-title":"Chemokines and Immunity","volume":"13","author":"Palomino","year":"2015","journal-title":"Einstein (S\u00e3o Paulo)"},{"key":"B54","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1111\/j.1365-2249.2006.03150.x","article-title":"Levels of Serum Chemokines Discriminate Clinical Myelopathy Associated With Human T Lymphotropic Virus Type 1 (HTLV-1)\/Tropical Spastic Paraparesis (HAM\/TSP) Disease From HTLV-1 Carrier State","volume":"145","author":"Guerreiro","year":"2006","journal-title":"Clin Exp Immunol"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1089\/aid.2016.0296","article-title":"Mediators Go Together: High Production of CXCL9, CXCL10, IFN-\u03b3, and TNF-\u03b1 in HTLV-1-Associated Myelopathy\/Tropical Spastic Paraparesis","volume":"33","author":"Neco HVP da","year":"2017","journal-title":"AIDS Res Hum Retroviruses"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2990.2010.01089.x","article-title":"Review: The Chemokine Receptor CXCR3 and its Ligands CXCL9, CXCL10 and CXCL11 in Neuroimmunity - a Tale of Conflict and Conundrum: CXCR3 and its Ligands in CNS Inflammation","volume":"36","author":"M\u00fcller","year":"2010","journal-title":"Neuropathol Appl Neurobiol"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2020.00421","article-title":"The Role of Chemokines in the Pathogenesis of HTLV-1","volume":"11","author":"Zargari","year":"2020","journal-title":"Front Microbiol"},{"key":"B58","doi-asserted-by":"publisher","first-page":"e81007","DOI":"10.1371\/journal.pone.0081007","article-title":"Feasibility of the Use of Combinatorial Chemokine Arrays to Study Blood and CSF in Multiple Sclerosis","volume":"8","author":"Edwards","year":"2013","journal-title":"PloS One"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1038\/srep33569","article-title":"CXCL13, CXCL10 and CXCL8 as Potential Biomarkers for the Diagnosis of Neurosyphilis Patients","volume":"6","author":"Wang","year":"2016","journal-title":"Sci Rep"},{"key":"B60","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/s12974-017-0907-5","article-title":"CXCL11 Production in Cerebrospinal Fluid Distinguishes Herpes Simplex Meningitis From Herpes Simplex Encephalitis","volume":"14","author":"Lind","year":"2017","journal-title":"J Neuroinflamm"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1016\/j.yfrne.2011.12.002","article-title":"Cytokines and Brain Excitability","volume":"33","author":"Galic","year":"2012","journal-title":"Front Neuroendocrinol"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2016.00071","article-title":"Oligodendrocyte, Astrocyte, and Microglia Crosstalk in Myelin Development, Damage, and Repair","volume":"4","author":"Domingues","year":"2016","journal-title":"Front Cell Dev Biol"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1007\/s004010050435","article-title":"Expression of Adhesion Molecules and Monocyte Chemoattractant Protein-1 (MCP-1) in the Spinal Cord Lesions in HTLV-I-Associated Myelopathy","volume":"91","author":"Umehara","year":"1996","journal-title":"Acta Neuropathol"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1177\/1352458514537365","article-title":"Interleukin-8 is Associated With Acute and Persistent Dysfunction After Optic Neuritis","volume":"20","author":"Rossi","year":"2014","journal-title":"Mult Scler"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1007\/s12272-013-0161-z","article-title":"Role of Chemokine CCL2 and its Receptor CCR2 in Neurodegenerative Diseases","volume":"36","author":"Bose","year":"2013","journal-title":"Arch Pharm Res"},{"key":"B66","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1136\/jnnp.72.4.498","article-title":"Expression of Chemokines in the CSF and Correlation With Clinical Disease Activity in Patients With Multiple Sclerosis","volume":"72","author":"Mahad","year":"2002","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B67","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1111\/jnc.13881","article-title":"Cerebrospinal Fluid Biomarkers as a Measure of Disease Activity and Treatment Efficacy in Relapsing-Remitting Multiple Sclerosis","volume":"141","author":"Novakova","year":"2017","journal-title":"J Neurochem"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.4067\/S0716-97602008000300001","article-title":"Microtubule Proteins and Their Post-Translational Forms in the Cerebrospinal Fluid of Patients With Paraparesis Associated With HTLV-I Infection and in SH-SY5Y Cells: An In Vitro Model of HTLV-I-Induced Disease","volume":"41","author":"Maldonado","year":"2008","journal-title":"Biol Res"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2005.03.015","article-title":"Neurofilament Phosphoforms: Surrogate Markers for Axonal Injury, Degeneration and Loss","volume":"233","author":"Petzold","year":"2005","journal-title":"J Neurol Sci"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1089\/aid.2008.0262","article-title":"Comparative Study of CSF Neurofilaments in HTLV-1-Associated Myelopathy\/Tropical Spastic Paraparesis and Other Neurological Disorders","volume":"25","author":"Alberti","year":"2009","journal-title":"AIDS Res Hum Retroviruses"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1002\/ana.24552","article-title":"Neurofilament Levels as Biomarkers in Asymptomatic and Symptomatic Familial Amyotrophic Lateral Sclerosis: Biomarkers in ALS","volume":"79","author":"Weydt","year":"2016","journal-title":"Ann Neurol"},{"key":"B72","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s13195-018-0426-3","article-title":"Non-Beta-Amyloid\/Tau Cerebrospinal Fluid Markers Inform Staging and Progression in Alzheimer\u2019s Disease","volume":"10","author":"Gangishetti","year":"2018","journal-title":"Alz Res Ther"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1086\/518043","article-title":"Elevated Cerebrospinal Fluid Neurofilament Light Protein Concentrations Predict the Development of AIDS Dementia Complex","volume":"195","author":"Gissl\u00e9n","year":"2007","journal-title":"J Infect Dis"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-1759(03)00189-3","article-title":"A Specific ELISA for Measuring Neurofilament Heavy Chain Phosphoforms","volume":"278","author":"Petzold","year":"2003","journal-title":"J Immunol Methods"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.737941\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,26]],"date-time":"2021-10-26T07:20:57Z","timestamp":1635232857000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.737941\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,26]]},"references-count":74,"alternative-id":["10.3389\/fimmu.2021.737941"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2021.737941","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,26]]},"article-number":"737941"}}